News|Articles|December 2, 2004
- Pharmaceutical Technology-12-02-2004
- Volume 28
- Issue 11
Robust CRO Market Is Driving New Merger and Acquisition Activity
Author(s)Jim Miller
The blockage in the new product pipeline may be breaking. CROs report increased demand for late-stage development services in their latest round of earnings reports.
Advertisement
Articles in this issue
about 21 years ago
In the Spotlight-December 2004about 21 years ago
Safety Problems Roil Pharma and FDAabout 21 years ago
December 2004about 21 years ago
The Seventh Annual International Employment Surveyabout 21 years ago
Pharmaco-FakeryNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
2
PharmTech Weekly News Roundup – Week of December 1, 2025
3
Immortal Dragons Will Help Etheros Target Aging and Related Diseases
4
Drug Digest: Closing the Gap in Modern Process Control and Automation for QC/QA
5
